Abul Mehmet Süleyman, Şahiner Duygu, Sevim Ömer Faruk, Hekim Ömer, Ergün Selim, Eceviz Engin
Department of Orthopaedics and Traumatology, Kartal Dr. Lüt! Kirdar City Hospital, University of Health Sciences, Istanbul, Türkiye.
Department of Orthopedics and Traumatology, Kagizman State Hospital, Kars, Türkiye.
Acta Orthop Traumatol Turc. 2025 Jul 18;59(4):195-200. doi: 10.5152/j.aott.2025.25271.
Objective: This study aimed to evaluate the clinical outcomes of preserving and repairing the bursal tissue-rather than excising it-during total hip arthroplasty (THA), and to assess the additional e!ect of administering a steroid injection into the repaired bursa. Methods: Patients who underwent total hip arthroplasty (THA) via a posterior approach were retrospectively reviewed and divided into three groups based on the intraoperative bursal tissue management technique. The first group (PB) included patients who received an intraoperative injection of corticosteroid (40 mg methylprednisolone) and local anesthetic (bupivacaine 5 mg/mL) into the pre- served bursa. The second group (BR) consisted of patients who underwent bursal repair without injection. The third group (BE) comprised patients who underwent total excision of the bursa. Clinical outcomes were assessed using the Harris Hip Score (HHS), the Visual Analogue Scale (VAS) for pain during daily activities, and VAS for pain while lying on the ipsilateral hip at 6 and 24 months postoperatively. Results: A total of 41 patients (27 females, 14 males) who underwent THA were included in the study. No statistically significant di!erences were observed between the groups in lateral trochanteric VAS scores during daily activities at both 6 and 24 months postoperatively (P > .05). However, a significant di!erence was found in VAS scores assessed while lying on the operated side at 6 months, favoring the PB group (P < .001). Additionally, Harris Hip Score (HHS) values were significantly higher in the PB group compared to the other groups at both 6 months (P < .001) and 24 months (P = .006). Conclusion: Intraoperative corticosteroid and local anesthetic injection, in addition to bursa repair, may improve early postoperative outcomes and pain relief in patients undergoing THA using the posterior approach, without increasing infection risk.
本研究旨在评估在全髋关节置换术(THA)中保留和修复滑囊组织而非切除滑囊组织的临床效果,并评估向修复后的滑囊内注射类固醇的额外效果。方法:回顾性分析经后路行全髋关节置换术(THA)的患者,并根据术中滑囊组织管理技术将其分为三组。第一组(PB)包括术中向保留的滑囊内注射皮质类固醇(40mg甲泼尼龙)和局部麻醉剂(布比卡因5mg/mL)的患者。第二组(BR)由未注射而行滑囊修复的患者组成。第三组(BE)包括行滑囊完全切除的患者。使用Harris髋关节评分(HHS)、日常活动时疼痛的视觉模拟量表(VAS)以及术后6个月和24个月时患侧卧位疼痛的VAS对临床效果进行评估。结果:本研究共纳入41例行THA的患者(27例女性,14例男性)。术后6个月和24个月时,三组患者日常活动时大转子外侧VAS评分无统计学显著差异(P>.05)。然而,在术后6个月时,患侧卧位评估的VAS评分存在显著差异,PB组更具优势(P<.001)。此外,在术后6个月(P<.001)和24个月(P=.006)时,PB组的Harris髋关节评分(HHS)值均显著高于其他组。结论:除滑囊修复外,术中注射皮质类固醇和局部麻醉剂可能改善采用后路行THA患者的术后早期效果和疼痛缓解情况,且不增加感染风险。